Tyvense Capsules, hard - Introduction of a New Contraindication - Pheochromocytoma
22/05/2026
Medicines for human use
Product information update (PIU)
An update was made to add pheochromocytoma as a contraindication to Tyvense.
Product information
- Product name
- Tyvense
- Active substance
- Lisdexamfetamine dimesylate
- Authorisation holder
- Takeda
- Authorisation number
-
PA23211/005/001-006
- Human or veterinary medicine
- Human